MA58262B1 - Composition destinée à être utilisée dans un traitement d'anomalies de cellules cervicales contenant un composé de sélénite et d'acide - Google Patents

Composition destinée à être utilisée dans un traitement d'anomalies de cellules cervicales contenant un composé de sélénite et d'acide

Info

Publication number
MA58262B1
MA58262B1 MA58262A MA58262A MA58262B1 MA 58262 B1 MA58262 B1 MA 58262B1 MA 58262 A MA58262 A MA 58262A MA 58262 A MA58262 A MA 58262A MA 58262 B1 MA58262 B1 MA 58262B1
Authority
MA
Morocco
Prior art keywords
acid
selenite
composition
cervical cell
treatment
Prior art date
Application number
MA58262A
Other languages
English (en)
French (fr)
Inventor
Norbert Fuchs
Original Assignee
Selo Medical Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Selo Medical Gmbh filed Critical Selo Medical Gmbh
Publication of MA58262B1 publication Critical patent/MA58262B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MA58262A 2020-03-03 2021-03-03 Composition destinée à être utilisée dans un traitement d'anomalies de cellules cervicales contenant un composé de sélénite et d'acide MA58262B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20160817.1A EP3875083A1 (en) 2020-03-03 2020-03-03 Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid
PCT/EP2021/055230 WO2021175877A1 (en) 2020-03-03 2021-03-03 Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid

Publications (1)

Publication Number Publication Date
MA58262B1 true MA58262B1 (fr) 2024-03-29

Family

ID=69770560

Family Applications (1)

Application Number Title Priority Date Filing Date
MA58262A MA58262B1 (fr) 2020-03-03 2021-03-03 Composition destinée à être utilisée dans un traitement d'anomalies de cellules cervicales contenant un composé de sélénite et d'acide

Country Status (23)

Country Link
US (1) US20230092142A1 (cg-RX-API-DMAC7.html)
EP (2) EP3875083A1 (cg-RX-API-DMAC7.html)
JP (1) JP7840859B2 (cg-RX-API-DMAC7.html)
CN (1) CN115279358A (cg-RX-API-DMAC7.html)
AR (1) AR122387A1 (cg-RX-API-DMAC7.html)
AU (1) AU2021231205B2 (cg-RX-API-DMAC7.html)
BR (1) BR112022017436A2 (cg-RX-API-DMAC7.html)
CL (1) CL2022002363A1 (cg-RX-API-DMAC7.html)
CY (1) CY1126764T1 (cg-RX-API-DMAC7.html)
ES (1) ES2976058T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20240374T1 (cg-RX-API-DMAC7.html)
HU (1) HUE066384T2 (cg-RX-API-DMAC7.html)
IL (1) IL296146A (cg-RX-API-DMAC7.html)
MA (1) MA58262B1 (cg-RX-API-DMAC7.html)
MD (1) MD4084788T2 (cg-RX-API-DMAC7.html)
MX (1) MX2022010838A (cg-RX-API-DMAC7.html)
PL (1) PL4084788T3 (cg-RX-API-DMAC7.html)
RS (1) RS65349B1 (cg-RX-API-DMAC7.html)
SM (1) SMT202400126T1 (cg-RX-API-DMAC7.html)
TW (1) TW202146004A (cg-RX-API-DMAC7.html)
UA (1) UA130108C2 (cg-RX-API-DMAC7.html)
WO (1) WO2021175877A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202208848B (cg-RX-API-DMAC7.html)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2406377C (en) 2000-05-10 2010-07-06 Okopharm Forschungs-Und Entwicklungs-Gmbh Method for reducing the surface area of silicon dioxide
AT412758B (de) 2000-06-05 2005-07-25 Vis Vitalis Lizenz & Handels Verwendung einer selenithältigen lösung zur behandlung viraler erkrankungen
AT412703B (de) 2001-12-04 2005-06-27 Vis Vitalis Lizenz & Handels Verwendung von selenithältigen präparaten zur topischen oder bukkalen anwendung
AT511159A1 (de) * 2011-02-16 2012-09-15 Selo Medical Gmbh Pharmazeutische zusammensetzungen enthaltend selenit- oder selenathältige verbindungen
EP3616693A1 (en) * 2018-08-28 2020-03-04 Selo Medical GmbH Therapy of high-risk human papillomavirus infections

Also Published As

Publication number Publication date
JP2023516153A (ja) 2023-04-18
EP3875083A1 (en) 2021-09-08
MD4084788T2 (ro) 2024-06-30
BR112022017436A2 (pt) 2022-10-18
HUE066384T2 (hu) 2024-07-28
PL4084788T3 (pl) 2024-06-03
UA130108C2 (uk) 2025-11-12
EP4084788B1 (en) 2024-02-14
CL2022002363A1 (es) 2023-03-31
ZA202208848B (en) 2024-09-25
ES2976058T3 (es) 2024-07-22
AU2021231205A1 (en) 2022-09-01
MX2022010838A (es) 2022-09-27
CY1126764T1 (el) 2026-02-25
WO2021175877A1 (en) 2021-09-10
CN115279358A (zh) 2022-11-01
RS65349B1 (sr) 2024-04-30
SMT202400126T1 (it) 2024-05-14
AR122387A1 (es) 2022-09-07
EP4084788A1 (en) 2022-11-09
HRP20240374T1 (hr) 2024-06-07
JP7840859B2 (ja) 2026-04-06
AU2021231205B2 (en) 2026-02-26
TW202146004A (zh) 2021-12-16
EP4084788C0 (en) 2024-02-14
CA3167015A1 (en) 2021-09-10
US20230092142A1 (en) 2023-03-23
IL296146A (en) 2022-11-01

Similar Documents

Publication Publication Date Title
US5973002A (en) Prostaglandin E1 derivatives as pharmacologically active agents, especially for transcutaneous administration
JP4804004B2 (ja) 関節軟骨細胞外マトリクス分解阻害剤
FR2547727A1 (fr) Compositions pharmaceutiques
BE895724A (fr) Nouvelle utilisation therapeutique de la dihydrocyclosporine d
EP0308564B1 (fr) Composition inhibitrice ou destructrice d'au moins un être vivant unicellulaire renfermant un fluorure d'ammononium quaternaire et procédé de préparation de ce sel
CA1327359C (en) Prostaglandin el derivatives as pharmacologically active agents, and pharmaceutical compositions containing these compounds, especially for transcutaneous administration
MA27762A1 (fr) Utilisation de derives de 10-hydroxy-10, 11-dihydrocarbamazepine pour le traitement de troubles affectifs
MA53482B1 (fr) Thérapie d'infections par le papillomavirus humain à haut risque
RU2367421C1 (ru) Способ коррекции эндотелиальной дисфункции ламотриджином при l-name индуцированном дефиците оксида азота
FR2788436A1 (fr) Composition d'un derive de phenothiazine
RU2201212C1 (ru) Суппозитории "генферон", обладающие иммуномодулирующим, противовирусным, противобактериальным, регенерирующим, репаративным, мембрано- и гепатопротекторным действием
CA1029659A (en) PREPARATION OF 3,20-DIOXO 16.alpha.-METHYL PREGNA 1,4,9(11)-TRIENES
Willcox An imidazole derivative (Flagyl) effective orally in vaginal trichomoniasis
CA2087379A1 (fr) Derives pseudopeptidiques a activite antagoniste de la bradykinine, leur procede de preparation et les compositions pharmaceutiques qui en contiennent
RU2590980C2 (ru) Фармацевтическая композиция для местного применения, обладающая антибактериальным, противовоспалительным и иммуномодулирующим действием, и ее применения
CN1055620C (zh) 氢碘酸水溶液在制备催欲药中的用途
Noguchi et al. Aspects of the pharmacology and pharmacokinetics of nitroimidazoles with special reference to tinidazole
JPWO2021176707A5 (cg-RX-API-DMAC7.html)
CN1909917A (zh) 具有催产素拮抗特性的物质用于制备治疗高血压的药物
RU2134098C1 (ru) Способ лечения воспалительных заболеваний пародонта
ZA202208848B (en) Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid
CA1255600A (fr) Compositions pharmaceutiques contenant comme ingredient actif l'acetyl-10 triacetoxy-1,8,9 anthracene
SU1395328A1 (ru) Способ лечени диффузного нейродермита
Pasyk et al. The effectiveness of different Pimaricin (Natamycin) preparations in the local treatment of mycotic infections
EP0608648B1 (fr) Composition contenant une très forte quantité de vitamines A pour une dose